Clinical Trial

Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation

Study acronym: EASE-AF
Recruiting
View on ClinicalTrials.gov →
Summary
Atrial fibrillation (AF) affects 1 in 4 individuals during their lifetime and continues to increase in frequency and impact. Exercise intervention has established benefits to improve AF symptoms and burden in clinical studies. However, lack of access to exercise programs has limited therapeutic adoption. The growth of technology-driven health care and diagnostics, recognized as an emerging priority by the American Heart Association, offers an opportunity for a pragmatic and patient-centered approach to meet this need. EASE-AF is a prospective, interventional study with a sequential run-in control to evaluate if a digital health-driven, patient-centered exercise intervention improves AF symptoms and burden. The research team will enroll 120 patients with symptomatic, paroxysmal AF. The main impact of this study will be the establishment of evidence for a novel, pragmatic paradigm for a patient-centered, digital technology-driven personalized exercise intervention for patients with AF.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-14; most recent amendment 2026-05-19.
Status change: Not Yet Recruiting → Recruiting 2025-09-23
Trial Details
NCT Number NCT06938412
Lead Sponsor Icahn School of Medicine at Mount Sinai
Collaborators: American Heart Association
Conditions Atrial Fibrillation, Arrhythmias, Cardiac, Cardiovascular Diseases
Enrollment 120 participants
Start Date 2026-06-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-22